HEI10 negatively regulates cell invasion by inhibiting cyclin B/Cdk1 and other promotility proteins

Oncogene

Volumn 26, Issue 33, 2007, Pages 4825-4832

  Singh, M K ^a   Nicolas, E ^a   Gherraby, W ^a   Dadke, D ^a,b   Lessin, S ^a   Golemis, E A ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b MANIPAL HOSPITAL   (India)

Author keywords

Cdk1; Cell cycle; Cyclin B; HEI10; Invasion; Migration

Indexed keywords

CELL CYCLE PROTEIN; CRK ASSOCIATED SUBSTRATE PROTEIN; CYCLIN B; CYCLIN DEPENDENT KINASE 1; HUMAN ENHANCER OF INVASION CLONE 10 PROTEIN; MERLIN; PAXILLIN; REGULATOR PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CDC2 PROTEIN KINASE; CDC42 GTP-BINDING PROTEIN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CISPLATIN; CRK-ASSOCIATED SUBSTRATE PROTEIN; CYCLIN B; FLOW CYTOMETRY; HUMANS; MICROSCOPY, FLUORESCENCE; PAXILLIN; PROTEIN KINASE INHIBITORS; PURINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, SMALL INTERFERING; TIME FACTORS;

EID: 34447643227     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210282     Document Type: Article

References (26)

1. Bouton AH, Burnham MR. (1997). Detection of distinct pools of the adapter protein p130CAS using a panel of monoclonal antibodies. Hybridoma 16: 403-411.
2. Brabek J, Constancio SS, Siesser PF, Shin NY, Pozzi A, Hanks SK. (2005). Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells. Mol Cancer Res 3: 307-315.
3. Draviam VM, Orrechia S, Lowe M, Pardi R, Pines J. (2001). The localization of human cyclins B1 and B2 determines CDK1 substrate specificity and neither enzyme requires MEK to disassemble the Golgi apparatus. J Cell Biol 152: 945-958.
4. Evans DG, Sainio M, Baser ME. (2000). Neurofibromatosis type 2. J Med Genet 37: 897-904.
5. Fesik SW. (2005). Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 5: 876-885.
6. Gronholm M, Muranen T, Toby GG, Utermark T, Hanemann CO, Golemis EA et al. (2006). A functional association between merlin and HEI10, a cell cycle regulator. Oncogene 25: 4389-4398.
7. Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100: 57-70.
8. Hirokawa Y, Tikoo A, Huynh J, Utermark T, Hanemann CO, Giovannini M et al. (2004). A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor. Cancer J 10: 20-26.
9. Jackson PK, Eldridge AG, Freed E, Furstenthal L, Hsu JY, Kaiser BK et al. (2000). The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends in Cell Biol 10: 429-439.
10. James MF, Beauchamp RL, Manchanda N, Kazlauskas A, Ramesh V. (2004). A NHERF binding site links the betaPDGFR to the cytoskeleton and regulates cell spreading and migration. J Cell Sci 117: 2951-2961.
11. Juliano R. (2003). Movin' on through with Cdc2. Nat Cell Biol 5: 589-590.
12. Kaempchen K, Mielke K, Utermark T, Langmesser S, Hanemann CO. (2003). Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells. Hum Mol Genet 12: 1211-1221.
13. Klemke RL, Leng J, Molander R, Brooks PC, Vuori K, Cheresh DA. (1998). CAS/Crk coupling serves as a 'molecular switch' for induction of cell migration. J Cell Biol 140: 961-972.
14. Manes T, Zheng DQ, Tognin S, Woodard AS, Marchisio PC, Languino LR. (2003). Alpha(v)beta3 integrin expression upregulates cdc2, which modulates cell migration. J Cell Biol 161: 817-826.
15. Mine N, Kurose K, Konishi H, Araki T, Nagai H, Emi M. (2001). Fusion of a sequence from HEI10 (14q11) to the HMGIC gene at 12q15 in a uterine leiomyoma. Jpn J Cancer Res 92: 135-139.
16. Nymark P, Wikman H, Ruosaari S, Hollmen J, Vanhala E, Karjalainen A et al. (2006). Identification of specific gene copy number changes in asbestos-related lung cancer. Cancer Res 66: 5737-5743.
17. Poulikakos PI, Xiao GH, Gallagher R, Jablonski S, Jhanwar SC, Testa JR. (2006). Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK. Oncogene 25: 5960-5968.
18. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N et al. (2005). Towards a proteome-scale map of the human protein-protein interaction network. Nature 437: 1173-1178.
19. Ruest PJ, Roy S, Shi E, Mernaugh RL, Hanks SK. (2000). Phosphospecific antibodies reveal focal adhesion kinase activation loop phosphorylation in nascent and mature focal adhesions and requirement for the autophosphorylation site. Cell Growth Differ 11: 41-48.
20. Schwikowski B, Uetz P, Fields S. (2000). A network of protein-protein interactions in yeast. Nat Biotechnol 18: 1257-1261.
21. Smith AP, Weeraratna AT, Spears JR, Meltzer PS, Becker D. (2004). SAGE identification and fluorescence imaging analysis of genes and transcripts in melanomas and precursor lesions. Cancer Biol Ther 3: 104-109.
22. Toby GG, Gherraby W, Coleman TR, Golemis EA. (2003). A novel RING-finger protein, Human Enhancer of Invasion 10 (HEI10), alters mitotic progression through regulation of cyclin B levels. Mol Cell Biol 23: 2109-2122.
23. Wade R, Vande Pol S. (2006). Minimal features of paxillin that are required for the tyrosine phosphorylation of focal adhesion kinase. Biochem J 393: 565-573.
24. Worthylake RA, Burridge K. (2003). RhoA and ROCK promote migration by limiting membrane protrusions. J Biol Chem 278: 13578-13584.
25. Xiao GH, Gallagher R, Shetler J, Skele K, Altomare DA, Pestell RG et al. (2005). The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression. Mol Cell Biol 25: 2384-2394.
26. Zhao ZS, Manser E, Loo TH, Lim L. (2000). Coupling of PAK-interacting exchange factor PIX to GIT1 promotes focal complex disassembly. Mol Cell Biol 20: 6354-6363.